---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-103959"
form_type: "8-K"
ticker: "HYPD"
cik: "0001682639"
company_name: "HYPERION DEFI, INC."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:46:16.243997+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Eyenovia prices $4M registered direct offering of common stock and warrants at $0.46/unit

## Summary
- 8,695,653 shares (or equivalents) and 8,695,653 warrants sold at $0.46 per share and accompanying warrant.
- Gross proceeds ~$4M; closing expected September 30, 2024.
- Warrants exercisable at $0.50/share, begin 6 months post-issuance, expire March 2030.
- Net proceeds for Mydcombi and clobetasol commercialization, CHAPERONE myopia study, working capital, possible debt repayment.
- Lead placement agent A.G.P./Alliance Global Partners; co-agent Brookline Capital Markets.

## SEC filing metadata
- accession: 0001104659-24-103959
- form_type: 8-K
- ticker: HYPD
- cik: 0001682639
- company_name: HYPERION DEFI, INC.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682639/000110465924103959/0001104659-24-103959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682639/000110465924103959/tm2425134d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-103959
- JSON: https://secwatch.observer/filing/0001104659-24-103959.json
- Plain text: https://secwatch.observer/filing/0001104659-24-103959.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.